The MASAI Trial Just Made AI-Augmented Mammography the Standard of Care. The FDA Hasn’t Noticed.

Clinical Trial Perspectives: Precision Oncology, GLP-1 Imaging Gaps & AI Mammography Momentum

Clinical research is increasingly shaped not only by new therapies, but also by smarter diagnostics, improved endpoint selection, and precision…